BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3473284)

  • 1. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I; Kono N; Hara N; Shimizu T; Yamada Y; Kawachi M; Kiyokawa H; Wang YL; Tarui S
    N Engl J Med; 1987 Jul; 317(2):75-80. PubMed ID: 3473284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    Mineo I; Kono N; Shimizu T; Hara N; Yamada Y; Sumi S; Nonaka K; Tarui S
    J Clin Invest; 1985 Aug; 76(2):556-60. PubMed ID: 3861621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of exercise-induced hyperuricemia].
    Hadano S; Ogasawara M; Ito A
    Nihon Seirigaku Zasshi; 1987; 49(5):151-9. PubMed ID: 3681743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myogenic hyperuricemia].
    Yamasaki T; Hamaguchi T; Nakajima H; Matsuzawa Y
    Nihon Rinsho; 1996 Dec; 54(12):3343-8. PubMed ID: 8976117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma uric acid after exercise in muscle phosphofructokinase deficiency.
    Kono N; Mineo I; Shimizu T; Hara N; Yamada Y; Nonaka K; Tarui S
    Neurology; 1986 Jan; 36(1):106-8. PubMed ID: 2934643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis.
    Hara N; Mineo I; Kono N; Kiyokawa H; Kawachi M; Yamada Y; Nakajima H; Shimizu T; Kuwajima M; Wang YL
    Adv Exp Med Biol; 1989; 253A():381-6. PubMed ID: 2624217
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation.
    Jinnai K; Kono N; Yamamoto Y; Kanda F; Ohno S; Tsutsumi M; Yamada Y; Kawachi M; Tarui S; Fujita T
    Eur Neurol; 1993; 33(3):204-7. PubMed ID: 8467838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary hyperuricemia in glycogen storage disease types I, III, V and VII].
    Yamasaki T; Mineo I
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():307-12. PubMed ID: 12629737
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycogenosis (molecular mechanism of muscle glycogenosis)].
    Tarui S; Mineo I; Nakajima H; Kono N
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):637-42. PubMed ID: 3270875
    [No Abstract]   [Full Text] [Related]  

  • 11. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
    Edwards NL; Recker D; Fox IH
    J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. McArdle's disease and gout.
    Puig JG; de Miguel E; Mateos FA; Miranda E; Romera NM; Espinosa A; Gijón J
    Muscle Nerve; 1992 Jul; 15(7):822-8. PubMed ID: 1501625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxanthine.
    Sinkeler SP; Joosten EM; Wevers RA; Binkhorst RA; Oerlemans FT; van Bennekom CA; Coerwinkel MM; Oei TL
    Clin Sci (Lond); 1986 Apr; 70(4):399-401. PubMed ID: 3457669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte glycolysis and its marked alterations by muscular exercise in type VII glycogenosis.
    Shimizu T; Kono N; Kiyokawa H; Yamada Y; Hara N; Mineo I; Kawachi M; Nakajima H; Wang YL; Tarui S
    Blood; 1988 Apr; 71(4):1130-4. PubMed ID: 3162690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
    Brooke MH; Patterson VH; Kaiser KK
    Muscle Nerve; 1983; 6(3):204-6. PubMed ID: 6574314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and biochemical correlations in certain metabolic myopathies].
    de Barsy T
    Bull Mem Acad R Med Belg; 1992; 147(10):385-92; discussion 392-3. PubMed ID: 1303789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I.
    Greene HL; Wilson FA; Hefferan P; Terry AB; Moran JR; Slonim AE; Claus TH; Burr IM
    J Clin Invest; 1978 Aug; 62(2):321-8. PubMed ID: 276529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.
    Sinkeler S; Joosten E; Wevers R; Binkhorst R; Oei L
    Adv Exp Med Biol; 1986; 195 Pt B():517-23. PubMed ID: 3464164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low glucose-1, 6-bisphosphate and high fructose-2, 6-bisphosphate concentrations in muscles of patients with glycogenosis types VII and V.
    Yamada Y; Kono N; Nakajima H; Shimizu T; Kiyokawa H; Kawachi M; Ono A; Nishimura T; Kuwajima M; Tarui S
    Biochem Biophys Res Commun; 1991 Apr; 176(1):7-10. PubMed ID: 2018547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.